F. Furnari, T. Fenton, R. Bachoo, A. Mukasa, J. Stommel et al., Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes & Development, vol.21, issue.21, pp.2683-2710, 2007.
DOI : 10.1101/gad.1596707

R. Stupp, M. Hegi, W. Mason, M. Van-den-bent, M. Taphoorn et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

R. Mclendon, A. Friedman, D. Bigner, V. Meir, E. Brat et al., Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, vol.123, issue.7216, pp.1061-1068, 2008.
DOI : 10.1038/nature07385

S. Sperandio, I. De-belle, and D. Bredesen, An alternative, nonapoptotic form of programmed cell death, Proceedings of the National Academy of Sciences, vol.97, issue.26, pp.14376-14381, 2000.
DOI : 10.1073/pnas.97.26.14376

N. Hoa, J. Zhang, C. Delgado, M. Myers, L. Callahan et al., Human monocytes kill M-CSF-expressing glioma cells by BK channel activation, Laboratory Investigation, vol.263, issue.3, pp.115-129, 2007.
DOI : 10.1038/labinvest.3700506

F. Sugawara, G. Strobel, R. Strange, J. Siedow, G. Van-duyne et al., Phytotoxins from the pathogenic fungi Drechslera maydis and Drechslera sorghicola, Proceedings of the National Academy of Sciences, vol.84, issue.10, pp.3081-3085, 1987.
DOI : 10.1073/pnas.84.10.3081

T. Au, W. Chick, and P. Leung, The biology of ophiobolins, Life Sciences, vol.67, issue.7, pp.733-742, 2000.
DOI : 10.1016/S0024-3205(00)00668-8

C. Tipton, P. Paulsen, and R. Betts, Effects of Ophiobolin A on Ion Leakage and Hexose Uptake by Maize Roots, PLANT PHYSIOLOGY, vol.59, issue.5, pp.907-910, 1977.
DOI : 10.1104/pp.59.5.907

S. Cocucci, S. Morgutti, M. Cocucci, and L. Gianani, Effects of ophiobolin A on potassium permeability, transmembrane electrical potential and proton extrusion in maize roots, Plant Science Letters, vol.32, issue.1-2, pp.9-16, 1983.
DOI : 10.1016/0304-4211(83)90093-7

H. Fujiwara, K. Matsunaga, H. Kumagai, M. Ishizuka, and Y. Ohizumi, Ophiobolin A, a Novel Apoptosis-inducing Agent from Fungus Strain f-7438, Pharmacy and Pharmacology Communications, vol.6, issue.9, pp.427-431, 2000.
DOI : 10.1211/146080800128736312

J. Chen, R. Mckay, and L. Parada, Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells, Cell, vol.149, issue.1, pp.36-47, 2012.
DOI : 10.1016/j.cell.2012.03.009

C. Haar, P. Hebbar, G. Wallace, A. Das, W. Vandergrift et al., Drug Resistance in Glioblastoma: A Mini Review, Neurochemical Research, vol.11, issue.9, pp.1192-1200, 2012.
DOI : 10.1007/s11064-011-0701-1

E. Van-meir, T. Kikuchi, M. Tada, H. Li, A. Diserens et al., Analysis of the p53 gene and its expression in human glioblastoma cells, Cancer Res, vol.54, pp.649-652, 1994.

C. Gomez-manzano, J. Fueyo, A. Kyritsis, T. Mcdonnell, P. Steck et al., Characterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis, JNCI Journal of the National Cancer Institute, vol.89, issue.14, pp.1036-1044, 1997.
DOI : 10.1093/jnci/89.14.1036

K. Rottner and T. Stradal, Actin dynamics and turnover in cell motility, Current Opinion in Cell Biology, vol.23, issue.5, pp.569-578, 2011.
DOI : 10.1016/j.ceb.2011.07.003

V. Mégalizzi, Implication des récepteurs sigma et de leurs ligands dans la biologie des cancers Available at http:// theses.ulb.ac.be, pp.7042011-121707, 2011.

O. 'callaghan-sunol, C. Gabai, V. Sherman, and M. , Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence, Cancer Research, vol.67, issue.24, pp.11779-11788, 2007.
DOI : 10.1158/0008-5472.CAN-07-2441

G. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott et al., A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9367, 1995.
DOI : 10.1073/pnas.92.20.9363

A. Litwiniec, A. Grzanka, A. Helmin-basa, L. Gackowska, and D. Grzanka, Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins, Journal of Cancer Research and Clinical Oncology, vol.27, issue.Suppl 1, pp.717-736, 2010.
DOI : 10.1007/s00432-009-0711-4

A. Galvez, G. Gimenez-gallego, J. Reuben, L. Roy-contancin, P. Feigenbaum et al., Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus, J Biol Chem, vol.5, pp.11083-11090, 1990.

C. Ransom and H. Sontheimer, BK channels in human glioma cells, J Neurophysiol, vol.85, pp.790-803, 2001.

A. Weaver, X. Liu, and H. Sontheimer, Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells, Journal of Neuroscience Research, vol.36, issue.2, pp.224-234, 2004.
DOI : 10.1002/jnr.20240

S. Candia, M. Garcia, and R. Latorre, Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel, Biophysical Journal, vol.63, issue.2, pp.583-590, 1992.
DOI : 10.1016/S0006-3495(92)81630-2

G. Kaczorowski, H. Knaus, R. Leonard, O. Mcmanus, and M. Garcia, High-conductance calcium-activated potassium channels; Structure, pharmacology, and function, Journal of Bioenergetics and Biomembranes, vol.35, issue.3, pp.255-267, 1996.
DOI : 10.1007/BF02110699

P. Orio, P. Rojas, G. Ferreira, and R. Latorre, New Disguises for an Old Channel: MaxiK Channel ??-Subunits, Physiology, vol.17, issue.4, pp.156-161, 2002.
DOI : 10.1152/nips.01387.2002

O. Mcmanus, L. Helms, L. Pallanck, B. Ganetzky, R. Swanson et al., Functional role of the ?? subunit of high conductance calcium-activated potassium channels, Neuron, vol.14, issue.3, pp.645-650, 1995.
DOI : 10.1016/0896-6273(95)90321-6

H. Sontheimer, An Unexpected Role for Ion Channels in Brain Tumor Metastasis, Experimental Biology and Medicine, vol.233, issue.7, pp.779-791, 2008.
DOI : 10.3181/0711-MR-308

R. Furukawa, A. Maselli, S. Thomson, R. Lim, J. Stokes et al., Calcium regulation of actin crosslinking is important for function of the actin cytoskeleton in Dictyostelium, Journal of Cell Science, vol.116, issue.1, pp.187-196, 2003.
DOI : 10.1242/jcs.00220

A. Weaver, V. Bomben, and H. Sontheimer, Expression and function of calcium-activated potassium channels in human glioma cells, Glia, vol.298, issue.3, pp.223-233, 2006.
DOI : 10.1002/glia.20364

M. Grunnet and W. Kaufmann, Coassembly of Big Conductance Ca2+-activated K+ Channels and L-type Voltage-gated Ca2+ Channels in Rat Brain, Journal of Biological Chemistry, vol.279, issue.35, pp.36445-36453, 2004.
DOI : 10.1074/jbc.M402254200

G. Calenda, S. Suadicani, R. Iglesias, D. Spray, A. Melman et al., Silencing MaxiK Activity in Corporal Smooth Muscle Cells Initiates Compensatory Mechanisms to Maintain Calcium Homeostasis, The Journal of Sexual Medicine, vol.8, issue.8, pp.2191-2204, 2011.
DOI : 10.1111/j.1743-6109.2010.02180.x

B. Lallemand, F. Chaix, M. Bury, C. Bruyère, J. Ghostin et al., ): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity, Journal of Medicinal Chemistry, vol.54, issue.19, pp.6501-6513, 2011.
DOI : 10.1021/jm200285z

W. Berger, S. Spiegl-kreinecker, J. Buchroithner, L. Elbling, C. Pirker et al., Overexpression of the human major vault protein in astrocytic brain tumor cells, International Journal of Cancer, vol.126, issue.3, pp.377-382, 2001.
DOI : 10.1002/ijc.1486

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

O. Debeir, V. Mégalizzi, N. Warzée, R. Kiss, and C. Decaestecker, Videomicroscopic extraction of specific information on cell proliferation and migration in vitro, Experimental Cell Research, vol.314, issue.16, pp.2985-2998, 2008.
DOI : 10.1016/j.yexcr.2008.06.010

V. Mégalizzi, C. Decaestecker, O. Debeir, S. Spiegl-kreinecker, W. Berger et al., Screening of anti-glioma effects induced by sigma-1 receptor ligands: Potential new use for old anti-psychiatric medicines, European Journal of Cancer, vol.45, issue.16, pp.2893-2905, 2009.
DOI : 10.1016/j.ejca.2009.07.011

V. Mégalizzi, V. Mathieu, T. Mijatovic, P. Gailly, O. Debeir et al., 4-IBP, a ??1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of Proapoptotic and Proautophagic Drugs, Neoplasia, vol.9, issue.5, pp.358-369, 2007.
DOI : 10.1593/neo.07130

L. Calvé, B. Rynkowski, M. , L. Mercier, M. Bruyère et al., Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression, Neoplasia, vol.12, issue.9, pp.727-739, 2010.
DOI : 10.1593/neo.10526

G. Grynkiewicz, M. Poenie, and R. Tsien, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J Biol Chem, vol.260, pp.3440-3450, 1985.

S. Roger, M. Potier, C. Vandier, L. Guennec, J. Besson et al., Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1667, issue.2, pp.190-199, 2004.
DOI : 10.1016/j.bbamem.2004.10.002